Olanzapine-Induced Thrombocytopenia in a Patient With Chronic Schizophrenia: A Case Report
Syed Ali Bokhari, Hanan Butaher, Reem Saleem, Nahid M.Elhassan · 2024
Read Olanzapine-Induced Thrombocytopenia in a Patient With Chronic Schizophrenia: A Case Report by Syed Ali Bokhari, Hanan Butaher, Reem Saleem, Nahid M.Elhassan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11681948.txt.
Description
Syed Ali Bokhari, Hanan Butaher, Reem Saleem and Nahid Elhassan report a 2024 case of a low platelet count tied to a mind drug. The drug, olanzapine, treats schizophrenia and is known for weight and sugar effects. Blood effects are rare and can be missed. Their patient was a man in his thirties with long-term schizophrenia.
After years on the drug, his platelet counts stayed below the normal range. He had no bleeding or bruising, but the drop forced a change in care. A switch to a second drug at first brought back his symptoms. A paired plan then raised his counts while keeping him stable.
Catalog record
| CREATOR | Syed Ali Bokhari, Hanan Butaher, Reem Saleem, Nahid M.Elhassan |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |